U.S. Markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.04
    +0.40 (+0.88%)
     
  • Gold

    1,840.70
    -0.40 (-0.02%)
     
  • Silver

    24.22
    +0.13 (+0.55%)
     
  • EUR/USD

    1.2124
    -0.0025 (-0.2061%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • Vix

    20.66
    -0.62 (-2.91%)
     
  • GBP/USD

    1.3430
    -0.0023 (-0.1679%)
     
  • USD/JPY

    104.1550
    +0.2950 (+0.2840%)
     
  • BTC-USD

    18,910.06
    -47.96 (-0.25%)
     
  • CMC Crypto 200

    370.44
    -8.81 (-2.32%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Top Ranked Momentum Stocks to Buy for May 14th

Zacks Equity Research
·3 min read

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 14th:

Aldeyra Therapeutics, Inc. (ALDX): This biotechnology company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.1% over the last 60 days.

Aldeyra Therapeutics Inc Price and Consensus

Aldeyra Therapeutics Inc Price and Consensus
Aldeyra Therapeutics Inc Price and Consensus

Aldeyra Therapeutics Inc price-consensus-chart | Aldeyra Therapeutics Inc Quote

Aldeyra Therapeutics’ shares gained 35.1% over the last one month above the S&P 500’s rise of 2.1%. The company possesses a Momentum Score of A.

Aldeyra Therapeutics Inc Price

Aldeyra Therapeutics Inc Price
Aldeyra Therapeutics Inc Price

Aldeyra Therapeutics Inc price | Aldeyra Therapeutics Inc Quote

ChannelAdvisor Corporation (ECOM): This provider of software-as-a-service solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.7% over the last 60 days.

ChannelAdvisor Corporation Price and Consensus

ChannelAdvisor Corporation Price and Consensus
ChannelAdvisor Corporation Price and Consensus

ChannelAdvisor Corporation price-consensus-chart | ChannelAdvisor Corporation Quote

ChannelAdvisor’s shares gained 60.5% over the last one month. The company possesses a Momentum Score of B.

ChannelAdvisor Corporation Price

ChannelAdvisor Corporation Price
ChannelAdvisor Corporation Price

ChannelAdvisor Corporation price | ChannelAdvisor Corporation Quote

HTG Molecular Diagnostics, Inc. (HTGM): This commercial stage life sciences company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.

HTG Molecular Diagnostics Inc Price and Consensus

HTG Molecular Diagnostics Inc Price and Consensus
HTG Molecular Diagnostics Inc Price and Consensus

HTG Molecular Diagnostics Inc price-consensus-chart | HTG Molecular Diagnostics Inc Quote

HTG Molecular Diagnostics’ shares gained 23.4% over the last one month. The company possesses a Momentum Score of A.

HTG Molecular Diagnostics Inc Price

HTG Molecular Diagnostics Inc Price
HTG Molecular Diagnostics Inc Price

HTG Molecular Diagnostics Inc price | HTG Molecular Diagnostics Inc Quote

Glu Mobile Inc. (GLUU): This developer of free-to-play mobile games has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.

Glu Mobile Inc Price and Consensus

Glu Mobile Inc Price and Consensus
Glu Mobile Inc Price and Consensus

Glu Mobile Inc price-consensus-chart | Glu Mobile Inc Quote

Glu Mobile’s shares gained 54.7% over the last one month. The company possesses a Momentum Score of B.

Glu Mobile Inc Price

Glu Mobile Inc Price
Glu Mobile Inc Price

Glu Mobile Inc price | Glu Mobile Inc Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Zacks’ Single Best Pick to Double

From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This young company’s gigantic growth was hidden by low-volume trading, then cut short by the coronavirus. But its digital products stand out in a region where the internet economy has tripled since 2015 and looks to triple again by 2025.

Its stock price is already starting to resume its upward arc. The sky’s the limit! And the earlier you get in, the greater your potential gain.

Click Here, See It Free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
HTG Molecular Diagnostics, Inc. (HTGM) : Free Stock Analysis Report
 
Glu Mobile Inc. (GLUU) : Free Stock Analysis Report
 
ChannelAdvisor Corporation (ECOM) : Free Stock Analysis Report
 
Aldeyra Therapeutics, Inc. (ALDX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research